RAILY AESMED (02135) and Youxin signed a service agreement.
Ruili Medical Beauty (02135) announced that on December 5, 2023, the company entered into a service agreement with Youxin...
RAILY AESMED (02135) announced that on December 5, 2023, the company entered into a service agreement with Youxin, whereby Youxin is required to facilitate the completion of the transaction.
According to the service agreement, the services provided by Youxin to the company include: (a) communication and negotiation with Suneva, and facilitating the signing and completion of the supply agreement; and (b) facilitating the company to become the registration agent for Bellafill in China. The service fee is $1.3 million.
The announcement stated that the service agreement is aimed at having Youxin provide communication and negotiation services to reduce potential business risks, shorten the time required for the company to obtain and complete the supply agreement, and become the exclusive distributor of Bellafill in the Greater China region, thereby facilitating the company to complete the transaction with Suneva.
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025